Finally, it is possible that AD-resilient individuals had higher cerebrospinal fluid levels of fibrillogenic soluble 42-amino acid amyloid-beta-peptide (Aβ42) leading to lower levels in the brain, which have been shown to be associated with normal cognition, even in the presence of insoluble cerebral amyloid plaques [24]. The gene discussed is APP; the disease is Alzheimer disease.